Privacy voorkeur

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.


Trials and AF

This second program from the Cardiostim EHRA Europace 2014 discusses three trials regarding Atrial Fibrillation Prof. dr. Jonathan Halperin (New York, USA) shares the results of the IMPACT trial, which is a multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices. Dr. Michael Orlov (Boston, USA) talkes about the RATE registry trial. The RATE registry is a multicenter observational study of patients with devices followed between 2007 and 2012 in order to evaluate the clinical implications of device detected AT/AF. Dr. Atul Verma (Newmarket, Canada) presents the results of the DISCERN AF trial, looking at the effect of ablation on Asymptomatic Atrial Fibrillation.

  • Duration:
    00:18:20
  • Channels:
  • Tags: